The word ‘protein’ often makes one think of a steak dinner or a smoothie, but in the world of biotech protein therapeutics are forming the backbone of next-generation therapies and novel medicines…

Last week, biotech news hubs were ablaze with the unexpected departure of Hal Barron, GSK’s R&D chief. In August Barron will take the helm as CEO of Altos Labs, headquartered in San Francisco, Californa…

With JPM 2022 having finished up last week, new standout partnerships between promising biotech companies and profitable big pharma show that reciprocity between players…